Abstract
We performed a retrospective analysis of costs and time to treatment (TT) of 150 culture-confirmed TB cases: 100 sputum smear (SS) (+) and 50 SS(-). This group underwent GeneXpert® (GX) assay. Expenditures and TT of SS(-)/GX(+) cases were inferred from the SS(+) group. GX detected 68% of SS(-) cases.
Copyright © 2013 Elsevier Inc. All rights reserved.
MeSH terms
-
Adult
-
Aged
-
Bacteriological Techniques / economics*
-
Bacteriological Techniques / methods
-
Cost-Benefit Analysis
-
Delayed Diagnosis / economics
-
Delayed Diagnosis / prevention & control
-
Female
-
Hospitalization / statistics & numerical data
-
Humans
-
Male
-
Middle Aged
-
Mycobacterium
-
Mycobacterium tuberculosis / isolation & purification*
-
Reagent Kits, Diagnostic / economics*
-
Reagent Kits, Diagnostic / statistics & numerical data*
-
Retrospective Studies
-
Sensitivity and Specificity
-
Sputum / microbiology
-
Time Factors
-
Tuberculosis, Pulmonary / diagnosis*
-
Tuberculosis, Pulmonary / economics